News | Treatment Planning | April 27, 2018

RayStation Users Win Inaugural Treatment Planning World Championships

Worldwide competition determines which technologist and treatment planning system can produce the highest quality plan in an aggressive and limited timeframe

RayStation Users Win Inaugural Treatment Planning World Championships

April 27, 2018 — In the first World Championships of Treatment Planning, arranged by radiation oncology analytics company ProKnow and held March 1, 2018, RayStation users scored highest in two out of three treatment planning categories. The categories were proton, volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT). RayStation users reached five of the ten highest scores, with all submitted plans taken into consideration.

The objective of the World Championships of treatment planning is to determine what planner and planning system can produce the highest quality plan in an aggressive and limited timeframe. Professionals from over 30 countries participated.

RayStation user Dennie Fransen, senior radiation therapy technologist at Holland Proton Therapy Centre (HollandPTC), scored highest in the proton category, with all submitted plans considered. Fransen has extensive experience in treatment planning with several different planning systems and treatment techniques. Over the last 18 months, he has been using RayStation for intensity modulated proton therapy, which is one of the most advanced and accurate radiation therapy techniques.

"Participating in the inaugural World Championships in treatment planning was a fun experience. The ability to quickly produce high-quality proton plans in RayStation was a key factor for this competition”, said Fransen.

In the IMRT category, RaySearch research engineer Björn Andersson achieved the highest score using an automatic planning technique that he recently developed, which will be included in a future RayStation release.

The winning plan was thus produced with only minimal user interaction. After the competition had closed, the automatic planning technique was applied to the proton and VMAT categories as well, showing good results.

"I am of course delighted that my technique managed to produce a winning plan. Looking forward, I am very excited about the possibilities that automatic treatment planning will bring to radiation therapy", said Andersson.

For more information: www.raysearchlabs.com

 

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...